The US medical regulator, the FDA, has approved Johnson & Johnson’s COVID-19 vaccine for “emergency” use, the regulator said.
Three vaccines against coronavirus infection will now be used in the United States. Previously approved by Pfizer and Moderna.
The third vaccine will be manufactured by Janssen Pharmaceutica, a division of Johnson & Johnson. It is noted that the third drug is a vector one, in contrast to the first two vaccines. It uses the common cold virus and targets the spike protein on the surface of the virus. It will only require one injection.
The company plans to supply up to 20 million doses of vaccines by the end of March and up to 100 million doses by the end of June.